ORIGINAL RESEARCH
Accepted on 15 Sep 2025
Impact of an Aerosolized or Intramuscular Adenovirus Type 5-Vectored COVID-19 Vaccine on Fc-Mediated Immune Effector Functions in a Hybrid Immunity Population
doi 10.3389/fimmu.2025.1657235
- 361 views
- Frontiers in Immunology
- Vaccines and Molecular Therapeutics
- Research Topics
- Vaccines and Breakthrough Infections
Vaccines and Breakthrough Infections
6,487
Total downloads
34k
Total views and downloads
Articles
BRIEF RESEARCH REPORT
Accepted on 15 Sep 2025
SARS-CoV-2 vaccines induce a diverse spike-specific CD4+ T cell receptor repertoire in people living with HIV with low CD4 nadirs
doi 10.3389/fimmu.2025.1663819
- 381 views
OPINION
Accepted on 15 Sep 2025
One Hundred Years of BCG: The Journey of Tuberculosis Vaccination in Brazil
doi 10.3389/fimmu.2025.1655969
- 125 views
ORIGINAL RESEARCH
Published on 05 Sep 2025
Reduced spike specific T-cell responses in COVID-19 vaccinated subjects undergoing SARS-CoV-2 breakthrough infection
doi 10.3389/fimmu.2025.1657082
- 1,782 views
ORIGINAL RESEARCH
Published on 18 Aug 2025
A genome-wide association study identifies new loci associated with response to SARS-CoV-2 mRNA-1273 vaccine in a cohort of healthy healthcare workers
doi 10.3389/fimmu.2025.1639825
- 1,525 views
ORIGINAL RESEARCH
Published on 04 Aug 2025
Neutralizing antibody response to different COVID-19 vaccines in Brazil: the impact of previous infection and booster doses
doi 10.3389/fimmu.2025.1603612
- 1,419 views
BRIEF RESEARCH REPORT
Published on 28 Jul 2025
Hypertension attenuates COVID-19 vaccine protection in elderly patients: a retrospective cohort study
doi 10.3389/fimmu.2025.1612205
- 1,302 views
ORIGINAL RESEARCH
Published on 22 Jul 2025
Development and characterization of the genotype F attenuated mumps candidate strains
doi 10.3389/fimmu.2025.1629585
- 1,010 views
ORIGINAL RESEARCH
Published on 15 Jul 2025
Neutralizing antibody response to Omicron subvariants BA.1 and BA.5 in children and adolescents following the two-dose CoronaVac protocol (Immunita-002, Brazil): a 12-month longitudinal study
doi 10.3389/fimmu.2025.1589733
- 1,474 views
ORIGINAL RESEARCH
Published on 22 May 2025
Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy
doi 10.3389/fimmu.2025.1569151
- 1,906 views
- 1 citation
ORIGINAL RESEARCH
Published on 02 May 2025
Analysis of humoral and cellular immune activation up to 21 months after heterologous and homologous COVID-19 vaccination
doi 10.3389/fimmu.2025.1579163
- 1,659 views
ORIGINAL RESEARCH
Published on 16 Apr 2025
Isolation of human monoclonal antibodies from 4CMenB vaccinees reveals PorB and LOS as the main OMV components inducing cross-strain protection
doi 10.3389/fimmu.2025.1565862
- 2,355 views
